What are the types of diabetic retinopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Types of Diabetic Retinopathy

Diabetic retinopathy is classified into two major categories: Nonproliferative Diabetic Retinopathy (NPDR) and Proliferative Diabetic Retinopathy (PDR), with NPDR further subdivided into mild, moderate, and severe stages. 1

Primary Classification Framework

The classification system is based on the presence or absence of retinal neovascularization, which fundamentally determines prognosis and treatment approach:

Nonproliferative Diabetic Retinopathy (NPDR)

This represents the earlier phases of disease with no evidence of retinal neovascularization 1. NPDR progresses through three severity levels:

1. Mild NPDR

  • At least 1 microaneurysm present
  • Less severe than moderate NPDR findings 1

2. Moderate NPDR

  • Hemorrhages and/or microaneurysms exceeding standard photograph 2A
  • Soft exudates, venous beading, or intraretinal microvascular abnormalities (IRMA) present
  • Does not meet criteria for severe NPDR 1

3. Severe NPDR (Preproliferative)

Uses the "4-2-1 rule" - at least ONE of the following must be present 1:

  • (4) Severe intraretinal hemorrhages and microaneurysms in 4 quadrants
  • (2) Venous beading in 2 or more quadrants
  • (1) Moderate IRMA in 1 or more quadrants

This stage carries high risk for progression to proliferative disease and warrants close monitoring.

Proliferative Diabetic Retinopathy (PDR)

Advanced disease characterized by neovascularization on the optic disc (NVD) and/or new vessels elsewhere in the retina (NVE) 1. This represents the sight-threatening stage where abnormal new blood vessels develop in response to retinal ischemia.

High-Risk PDR

A critical subcategory defined by 1:

  • NVD on or within 1 disc diameter of the optic disc equaling or exceeding one-quarter to one-third disc area (standard photograph 10A), with or without vitreous/preretinal hemorrhage
  • OR vitreous and/or preretinal hemorrhage accompanied by any NVD less than standard photograph 10A or NVE equaling or exceeding one-quarter disc area

Diabetic Macular Edema (DME)

Macular edema can occur at ANY stage of diabetic retinopathy (either NPDR or PDR) and represents a separate but overlapping complication 2, 3, 4. DME involves thickening of the retina within 1-2 disc diameters of the macular center and directly threatens central vision 1.

Clinical Significance and Pitfalls

Critical distinction: The presence of neovascularization is the defining feature separating NPDR from PDR. IRMA can be difficult to distinguish from true neovascularization—IRMA represents dilated intraretinal vessels while neovascularization extends beyond the retinal plane 1. This distinction is crucial as it determines whether panretinal photocoagulation is indicated.

Common pitfall: Assuming all diabetic retinopathy follows a linear progression. While severe NPDR typically precedes PDR, macular edema can develop at any stage and may be the presenting feature even in mild NPDR 2, 4.

The classification system is based on the ETDRS (Early Treatment Diabetic Retinopathy Study) grading system using standard photographs, which provides objective, reproducible criteria for disease staging and treatment decisions 1.

References

Research

Diabetic retinopathy: Early diagnosis and effective treatment.

Deutsches Arzteblatt international, 2010

Research

Diabetic retinopathy.

Nature reviews. Disease primers, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.